The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Hantavirus Risk to US Public Remains Low, CDC Says

The risk from hantavirus to the general public remains very low, ⁠and the U.S. Centers for Disease Control and Prevention has more than 100 staff members actively working on...

Chronic Cough Tied to Greater Healthcare Burden

Unexplained or refractory chronic cough affects a small fraction of individuals but is associated with impaired health status, a higher number of medical visits, and higher healthcare costs.

Gut Microbe Blooms Linked to Lupus Kidney Disease

Intestinal blooms of Ruminococcus gnavus, which produce a novel lipoglycan toxin, are linked to a distinct lupus nephritis endotype characterized by platelet activation and neutrophil degranulation.

Scarring Alopecias More Common in Black People, Urban Areas

Primary lymphocytic cicatricial alopecias disproportionately affect women, Black individuals, and urban dwellers, a study finds.

Britain to Bring 10 People to UK for Precautionary Isolation After Hantavirus Outbreak

Britain said on Tuesday that 10 people from remote island territories, including cruise ship passengers and ⁠medical staff who had contact with confirmed cases in the...

Tests in Italy, Spain Come Back Negative in Global Hunt for Hantavirus

Seventeen people under observation in Italy and Spain for possible hantavirus infection have tested negative, the countries' health ministries said on Wednesday as...

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

The risk from hantavirus to the general public remains very low, ⁠and the U.S. Centers for Disease Control and Prevention has more than 100 staff members actively working on...

Unexplained or refractory chronic cough affects a small fraction of individuals but is associated with impaired health status, a higher number of medical visits, and higher healthcare costs.

Intestinal blooms of Ruminococcus gnavus, which produce a novel lipoglycan toxin, are linked to a distinct lupus nephritis endotype characterized by platelet activation and neutrophil degranulation.

Primary lymphocytic cicatricial alopecias disproportionately affect women, Black individuals, and urban dwellers, a study finds.

Britain said on Tuesday that 10 people from remote island territories, including cruise ship passengers and ⁠medical staff who had contact with confirmed cases in the...

Seventeen people under observation in Italy and Spain for possible hantavirus infection have tested negative, the countries' health ministries said on Wednesday as...

News All Time

US Says 18 Passengers Flown Back After Hantavirus Outbreak on Ship

U.S. Department of Health and Human Services officials said on Monday that 18 passengers from the luxury cruise ship hit by a hantavirus outbreak were flown back to the...

Hantavirus Protocol Breach At Dutch Hospital as Medics Race to Curb Spread

A Dutch hospital has quarantined 12 staff members as a preventive measure after blood and urine from a hantavirus patient were handled without observing strict protocols, as...

26-Year-Old Man With Posttransfusion Hyperhemolysis

Severe posttransfusion hyperhemolysis in a sickle cell patient produced profound anemia and lactic acidosis; terminal complement blockade with eculizumab stabilized hemolysis and enabled recovery.

Language Models as Emergency Room Decision Support

A Science study finds modern large language models often match or exceed physicians in emergency room diagnostic decisions, especially at initial triage, but real-world trials remain essential.

Exclusive-Kennedy's Health Officials Explored US Ban Of Some Widely Used Antidepressants, Sources Say

U.S. health department officials last week explored whether they could ban certain drugs in a widely prescribed class of antidepressants as Health Secretary Robert F....

Early Trauma May Shape Outcomes in Childhood-Onset Lupus

Adverse childhood experiences are common in children with systemic lupus erythematosus and are linked to higher odds of neuropsychiatric lupus, a cohort study finds.

Reduced Kidney Function Tied to Lower Remission Rates in RA

For patients with rheumatoid arthritis and reduced kidney function, remission after drug therapy is less likely than for patients with preserved kidney function.

Four Factors Keep ‘At-Risk’ Group Arthritis-Free at 10 Years

People with ‘good’ prognostic factors at baseline are less likely to progress to rheumatoid arthritis at 5 and 10 years after presentation, a cohort study finds.

MHRA Approves New Prophylactic for Rare Swelling Disorder

The MHRA has approved donidalorsen for long-term prevention of hereditary angioedema, a rare disorder causing potentially life-threatening swelling.

FDA Seeks Advice on Researching Drug Risks in Pregnancy

The FDA held a workshop on ways to improve collection of safety data on medicines used during pregnancy and released guidance for companies on postapproval pregnancy safety studies.

Mental Health Conditions Tied to Cancer Risk, Study Reveals

Depression, anxiety, and bipolar disorders are associated with increased risks for overall and site-specific cancers, a population-based study reports.

Gestational Weight Gain May Shape Allergic Disease Risk

Children may have higher odds of developing asthma, rhinitis, and allergic sensitization if their mothers have excessive weight gain during gestation, a study shows.

Small Study Shows One-time Cell Therapy Can Control HIV Infection

Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded in controlling the infection in a small first-in-human study, but researchers said...

New Paper Highlights Evidence for Congenital Lyme Disease

Evidence suggests Borrelia burgdorferi can cross the placenta and may be associated with adverse pregnancy outcomes.

Optimizing COVID-19 Care for Hospitalized Patients

Optimizing COVID-19 Care for Hospitalized Patients

Hepatorenal Syndrome Essentials: Strategies for Early and Effective Treatment

Hepatorenal Syndrome Essentials: Strategies for Early and Effective Treatment

Recommended News For You

Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

How to keep your prostate healthy and lower your risk of developing serious problems

Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.

Appropriate New Monoclonal for Immunocompromised Individuals to Prevent COVID-19.

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

Recommended Articles For You

Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection? 

Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights 

Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy 

Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

2.

Prostate cancer screening program beneficial in top decile of polygenic risk score

3.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

4.

Ineffective medication can remove the "worst fear" of schizophrenia.

5.

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

1.

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

2.

Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology

3.

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment

4.

The New Era of Oncology: Key Updates and Clinical Insights

5.

What Is Carboxyhemoglobin And How Can It Affect Your Health?

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

4.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

5.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot